JBS N.V.
JBSJBS N.V.'s three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it.
Biggest watch item: the price is not yet in a confirmed uptrend — timing risk, not thesis risk.
The price is between stages while the P/E sits at the 53rd percentile of its own 1-year range. Underneath, the last four quarters read deteriorating — profit −57.1% year on year, and 133% of the last 3 years' profit arrived as cash. What settles it: the next one or two quarters of delivery.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
JBS N.V. trades at $13.9, between stages. That is −3.4% against its own 200-day average. It sits at 32% of a 52-week range of $12 to $18. On relative strength it is currently behind the S&P 500 on a trailing-13-week view (14 weeks and counting).
Today the stock is between stages. At $13.9 it trades −3.4% versus its 200-day average and sits at 32% of its 52-week range ($12–$18).
Against the market, two honest reads. Cumulative: over the last 1.1 years the stock moved +3% while the S&P 500 moved +25% — behind the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (14 weeks and counting; last ahead the week of 2026-04-24) — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
→ The trend is one thing; the bill is another. Are you paying up for it? Next: the P/E sits at the 53rd percentile of its own range.
Valuation P/E is the price of $1 of annual profit: how many dollars the market pays for each dollar the company earns in a year.
JBS N.V. trades at 8.3× P/E, mid-range by its own standards (53rd percentile). Its long-run median P/E is 8.3×, measured across 1.1 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 8.3× is mid-range by its own standards (53rd percentile), against a long-run median of 8.3× measured over 1.1 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
Why the multiple sits where it does: over the past year annual EPS moved +14.5% against a +4.1% price move — earnings outran the price, pushing the multiple DOWN its own range.
Put together: the multiple is unremarkable against its own past, so the story rests on the earnings line underneath it, not the multiple.
→ Cheap or dear rides on the earnings. Are they actually growing? Next: the fundamental stage — where the business sits in its arc, and how growth has compounded.
Stage: Mixed Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
JBS N.V. reads as mixed on its fundamental arc. Mixed — no clean majority across the growth curves, ROCE slipping at 11.6% — the per-curve reads carry the story. The read is built from 12 quarters across 4 curves, on full evidence.
Why it matters: when the curves disagree, the per-curve reads above matter more than any single verdict.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +11.7% | +5.9% | — | — |
| Profit | +13.2% | −10.8% | — | — |
| EPS | +14.5% | +12.1% | — | — |
| Stock price | +4.1% | — | — | — |
→ The stage names the trajectory. Next: the revenue line that produces it, quarter by quarter.
4-Factor Sector Score
43.7/100 — rank 17 of 30 in Packaged Foods · 76% evidence confidence
JBS N.V. scores 43.7 out of 100 against the 30 companies it is compared with in Packaged Foods, ranking 17. Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
The four contributions add to the total exactly: 14.7 + 6.6 + 15.4 + 7 = 43.7. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
JBS N.V. reported $21.6 B of revenue in the Mar 26 quarter, +10.7% year on year. That is the 10th straight quarter of year-on-year growth. Over 4 years it has compounded at 7.3% a year. The last full year, FY25, came in at $86.2 B. The last four reported quarters add to $88.3 B.
JBS N.V. reported $21.6 B of revenue in the Mar 26 quarter, +10.7% year on year. That is the 10th straight quarter of year-on-year growth. Over 4 years it has compounded at 7.3% a year. The last full year, FY25, came in at $86.2 B. The last four reported quarters add to $88.3 B.
FY25 revenue came in at $86.2 B (+11.7% on the year), capping 4 years at 7.3% compound. The latest quarter (Mar 26) printed $21.6 B, +10.7% year on year — the 10th consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +12.1% growth against the decade's 7.3% — the current year is running faster than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +12.1% over the last 4 quarters against +8.8%/yr over the last 8 — accelerating; TTM profit −12.0% vs +99.5%/yr — rolling over.
→ Revenue grew — did margins hold as it scaled? Next: 2.2% this quarter (−2.3 pp YoY).
Operating margin Operating margin is what is left of every $100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
JBS N.V.'s operating margin is 2.2% in the Mar 26 quarter, −2.3 percentage points against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged 1.5% to 9.2%. The current quarter sits inside that band.
JBS N.V.'s operating margin is 2.2% in the Mar 26 quarter, −2.3 percentage points against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged 1.5% to 9.2%. The current quarter sits inside that band.
The latest quarter's operating margin is 2.2%, −2.3 pp against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged 1.5%–9.2%.
🚨 Why the margin moved: operating margin went −2.3 pp year on year while gross margin went −2.7 pp — the loss came mostly from the gross line: input costs and pricing.
→ Margins slipped — did that reach the bottom line? Next: profit −57.1% in the latest quarter.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
JBS N.V. earned $0.2 B of net profit in the Mar 26 quarter, −57.1% year on year. Full-year FY25 profit was $2.2 B. The 4-year compound rate is −12.6%. That is 1.1% of the quarter's revenue. The same quarter a year earlier earned $0.6 B. 1 of the last 12 reported quarters were loss-making.
JBS N.V. earned $0.2 B of net profit in the Mar 26 quarter, −57.1% year on year. Full-year FY25 profit was $2.2 B. The 4-year compound rate is −12.6%. That is 1.1% of the quarter's revenue. The same quarter a year earlier earned $0.6 B. 1 of the last 12 reported quarters were loss-making.
Mar 26 profit was $0.2 B, −57.1% year on year. On the full year, FY25 printed $2.2 B (+13.2%), and the 4-year compound rate is −12.6%.
🚨 Why profit moved: revenue contributed +10.7% and the margin −2.3 pp — the quarter was revenue-led despite a thinner margin.
Pace comparison, last four quarters: profit −6.5% vs revenue +12.1%. Profit is growing slower than sales — costs are eating the growth before it reaches the bottom line.
→ Profit rose — but did the cash follow? Next: 133% of the last 3 years' profit arrived as cash.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 133% of JBS N.V.'s reported profit arrived as operating cash — the cash follows the profit. In FY25 that was $2.9 B of operating cash against $2.2 B of profit. After $2.1 B of capital spending, $0.8 B was left as free cash.
FY25: operating cash of $2.9 B against reported profit of $2.2 B, leaving free cash of $0.8 B after $2.1 B of capital spending. Across the last 3 fiscal years the conversion rate is 133% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Why: conversion is measured cleanly, but the working-capital day-counts behind it sit below what we hold — the move is shown without inventing its driver.
Router verdict: the visible cash user is investment — the next section checks what the spending is buying.
→ So follow the cash to where it goes. Next: $5.0 B of building over 3 years.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
JBS N.V. does not report the debtor, inventory and payable day-counts a cash cycle is built from, so this section reads the investment side instead. Capital spending ran $5.0 B over the last 3 years. Averaged over those years that is 1.9% of FY25 revenue a year.
Working-capital day-counts are not in our numbers for this stock, so this section reads the investment side — where the cash is being put to work.
On the investment side: capital spending of $5.0 B over the last 3 fiscal years.
The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.
→ Does all this activity actually earn its cost of capital? Next: ROE is 22%.
Return on equity Return on equity (ROE) is the profit the business earns on its shareholders’ money. With the full capital-employed split not in our numbers, ROE is the cleanest long ladder we can draw here.
JBS N.V. earns a ROE of 23% in FY25. That is up from a trough of −1% in FY23. A return-on-invested-capital spread against the cost of capital is not computable from what is held here. The wiring behind it is 2.6% net margin on 1.91× asset turns.
FY25 ROE is 23%, recovered from a FY23 trough of −1% — the full ladder below shows the fall and the climb, undoctored.
Why the return is what it is — the wiring (FY25): 2.6% net margin × 1.91× asset turns × 4.74× balance-sheet leverage ≈ 23.5% on equity. Margin does its share; leverage is a meaningful part of the equation.
→ Returns like these — is the balance sheet borrowing to make them? Next: debt-to-equity is 2.68.
Dividend A dividend is cash paid out per share. Dividend per share is the declared amount for the period; the trailing twelve-month total is the four most recent quarters added together.
JBS N.V. has 2 quarters of declared dividends on file — too few for a trailing-twelve-month figure. The most recent declaration was $1.00 for Mar 26.
JBS N.V. has 2 quarters of declared dividends on file — too few for a trailing-twelve-month figure. The most recent declaration was $1.00 for Mar 26.
JBS N.V. has declared a dividend in 2 of the last 12 reported quarters, most recently $1.00 for Mar 26. That is fewer than four quarters, so no trailing-twelve-month total is shown rather than one built from a partial year.
→ A payout is cash leaving the business. Next: what the balance sheet looks like behind it.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.
JBS N.V. carries total debt of $23.1 B against shareholder equity of $9.1 B as of Mar 26, a debt-to-equity of 2.56. On the annual view that ratio went from 2.11 in FY21 to 2.40 in FY25. Read the returns elsewhere on this page with that leverage in mind.
Mar 26: total debt of $23.1 B against shareholder equity of $9.1 B — a debt-to-equity of 2.56. On the annual view, debt-to-equity went from 2.11 (FY21) to 2.40 (FY25). Read the returns on this page with that leverage in mind.
→ Who owns this, and are they adding or leaving? Next: short interest is 9.7% of the float.
Ownership There is no quarter-by-quarter holder register to read here, so we read the crowd through short interest — the slice of tradable shares currently sold short, positioned for a fall.
9.7% of JBS N.V.'s tradable float is currently sold short — some money is positioned against it. At typical trading volumes those positions would take about 5.0 days to buy back. There is no quarter-by-quarter holder register to read for this filer, so the crowd is read through short interest instead.
The latest reading: 9.7% of the float is sold short, and at typical trading volumes it would take about 5.0 days to buy those positions back. Some money is positioned against it. This is a single point-in-time reading — we do not yet hold its history, so we show no trend chart.
Why it sits there: who is doing the shorting, and why, does not travel with the number — the level is shown without inventing its story.
→ One last check: does the safety math agree? Next: the balance-sheet safety line.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
JBS N.V.: the Z-score reads 2.67. A Z-score above roughly 3 reads as safe and below roughly 1.8 as the distress zone, so this sits in the grey band between the two. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure.
Why it matters: a Z-score of 2.67 sits in the grey band — neither clearly safe nor clearly distressed.
The safety line in one sentence: the Z-score reads 2.67.
Frequently asked questions
What is JBS N.V.'s stock price today?
JBS N.V. trades at $13.9, +4.1% over the past year. The company is valued at $15.0 B. The stock sits at 32% of its 52-week range of $12–$18, −3.4% versus its 200-day average. Against the S&P 500 it has been behind on a trailing-13-week view for 14 weeks. — as of 29 July 2026.
What were JBS N.V.'s latest quarterly results?
JBS N.V. reported revenue of $21.6 B and net profit of $0.2 B for the Mar 26 quarter. Revenue rose 10.7% and profit fell 57.1% year on year. Earnings per share were $0.20. The operating margin was 2.2%, 2.3 pp lower than a year earlier. — as of 29 July 2026.
What is JBS N.V.'s revenue?
JBS N.V. reported revenue of $21.6 B in the Mar 26 quarter, +10.7% year on year. For the full FY25 fiscal year, revenue was $86.2 B (+11.7%). Over the last 4 years revenue compounded at 7.3% a year. — as of 29 July 2026.
What is JBS N.V.'s profit?
JBS N.V. earned $0.2 B of net profit in the Mar 26 quarter, −57.1% year on year. Full-year FY25 profit was $2.2 B. The operating margin ran 2.2% in the latest quarter. — as of 29 July 2026.
What is JBS N.V.'s market cap?
JBS N.V.'s market capitalisation is $15.0 B at a stock price of $13.9. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 29 July 2026.
What is JBS N.V.'s P/E ratio?
JBS N.V. trades at a P/E of 8.3×, at the 53rd percentile of its own 1-year range, against a long-run median of 8.3×. This is a comparison with the stock's own history, not a value call — as of 29 July 2026.
Does JBS N.V. pay a dividend?
Yes — JBS N.V. declared $1.00 per share for Mar 26 (2 quarters on file, too few for a trailing-twelve-month total). — as of 29 July 2026.
What is JBS N.V.'s dividend per share?
JBS N.V.'s most recently declared dividend is $1.00 per share for Mar 26. Each figure is the amount declared for that quarter as reported, added across four quarters for the trailing total. — as of 29 July 2026.
Is JBS N.V. overvalued?
On its own history, JBS N.V. looks mid-range against its own history: its P/E of 8.3× sits at the 53rd percentile of its 1-year range (long-run median 8.3×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 29 July 2026.
Is JBS N.V. growing?
Not right now — JBS N.V.'s latest numbers are shrinking: latest-quarter revenue +10.7% year on year, profit −57.1%, and the margin −2.3 pp at 2.2%. The 4-year compound rates are 7.3% (revenue) and −12.6% (profit). The earnings engine currently reads: deteriorating — as of 29 July 2026.
How is JBS N.V. performing?
JBS N.V.'s latest readings are below. Its latest quarter's revenue rose 10.7% and profit fell 57.1% year on year. Against the S&P 500 it has been behind on a trailing-13-week view for 14 weeks. This describes what the data did, not a rating. — as of 29 July 2026.
What stage is JBS N.V. in?
Mixed — no clean majority across the growth curves, ROCE slipping at 11.6% — the per-curve reads carry the story. The read comes from the last 12 quarters of growth (revenue growth +12.1% latest, profit growth −12.0% latest, eps growth +0.6% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 29 July 2026.
Is JBS N.V. beating the market?
Not lately — on a trailing-13-week view JBS N.V. is currently behind the S&P 500 (14 weeks and counting; last ahead the week of 2026-04-24), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 1.1 years the stock moved +3% against the S&P 500's +25% — behind the index over the full window. — as of 29 July 2026.
Will JBS N.V.'s stock price go up?
This page publishes no price forecast for JBS N.V. What it measures instead: the stock price is $13.9. Its P/E of 8.3× sits at the 53rd percentile of its own 1-year range. Direction is not something this site claims to know. — as of 29 July 2026.
Is the market betting against JBS N.V.?
Somewhat — short interest is 9.7% of JBS N.V.'s tradable float, about 5.0 days to cover at typical volumes. A moderate reading: some money is positioned against it. With no quarter-by-quarter holder register here, short interest is the cleanest crowd read we hold — as of 29 July 2026.
Does JBS N.V. have too much debt?
It carries real leverage — JBS N.V.'s debt-to-equity is 2.68. A year-by-year borrowings ladder is not in our numbers for this stock, so the latest reading is the cleanest hold. Read the returns on this page with that leverage in mind — as of 29 July 2026.
What is JBS N.V.'s capex?
JBS N.V. spent $5.0 B on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY25 alone that was $2.1 B. — as of 29 July 2026.
What is JBS N.V.'s cash flow?
JBS N.V. generated $2.9 B of operating cash flow in FY25 and $0.8 B of free cash flow after $2.1 B of capital spending. Reported profit that year was $2.2 B, so operating cash ran ahead of profit. — as of 29 July 2026.
Is JBS N.V.'s profit real cash?
Yes — over the last 3 fiscal years, 133% of JBS N.V.'s reported profit arrived as operating cash. In FY25, operating cash was $2.9 B against reported profit of $2.2 B. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 29 July 2026.
How financially safe is JBS N.V.?
On the balance sheet, the Z-score reads 2.67 — above roughly 3 is safe, below roughly 1.8 is the distress zone. That is in the grey band — neither clearly safe nor clearly distressed. — as of 29 July 2026.
Where is JBS N.V. in its business cycle?
JBS N.V.'s FY25 operating margin was 4.8%, against a 5-year band of 1.5%–9.2%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 2.2%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 29 July 2026.
What could break the JBS N.V. story?
Biggest watch item: the price is not yet in a confirmed uptrend — timing risk, not thesis risk. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 29 July 2026.
Is JBS N.V. a stock worth studying right now?
This is not investment advice. The machine read: JBS N.V.'s three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it. The sharpest open question: the next one or two quarters of delivery. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 29 July 2026.